These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7555504)

  • 1. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N; Stephenson JM; Fuller JH
    Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N; Stephenson JM; Fuller JH
    Diabetes Care; 1996 May; 19(5):423-30. PubMed ID: 8732703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
    Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
    Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
    Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
    Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study.
    Lloyd CE; Stephenson J; Fuller JH; Orchard TJ
    Diabetes Care; 1996 Mar; 19(3):219-25. PubMed ID: 8742565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Mattock MB; Cronin N; Cavallo-Perin P; Idzior-Walus B; Penno G; Bandinelli S; Standl E; Kofinis A; Fuller JH;
    Diabet Med; 2001 Jan; 18(1):59-67. PubMed ID: 11168343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes.
    Braffett BH; Rice MM; Young HA; Lachin JM
    PLoS One; 2019; 14(1):e0210367. PubMed ID: 30615671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study.
    Diabetologia; 1994 Mar; 37(3):278-85. PubMed ID: 8174842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
    Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
    Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study.
    Karamanos B; Porta M; Songini M; Metelko Z; Kerenyi Z; Tamas G; Rottiers R; Stevens LK; Fuller JH
    Diabetologia; 2000 Mar; 43(3):348-55. PubMed ID: 10768096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications.
    Yosipovitch G; Hodak E; Vardi P; Shraga I; Karp M; Sprecher E; David M
    Diabetes Care; 1998 Apr; 21(4):506-9. PubMed ID: 9571332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final adult height and its relationship to blood glucose control and microvascular complications in IDDM.
    Penfold J; Chase HP; Marshall G; Walravens CF; Walravens PA; Garg SK
    Diabet Med; 1995 Feb; 12(2):129-33. PubMed ID: 7743759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary risk factors in a group of patients with insulin dependent diabetes mellitus--examination of the EURODIAB IDDM Complications Study Krakow].
    Idzior-Waluś B; Solnica B; Szopinska-Ciba L; Sieradzki J
    Przegl Lek; 1994; 51(11):468-74. PubMed ID: 7871192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.